Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2012
12/19/2012EP2534257A2 Methods for identifying and isolating cells expressing a polypeptide
12/19/2012EP2534255A1 Method of reducing glycosylation of proteins, processes and proteins thereof
12/19/2012EP2534249A2 Method for preparing recombinant glycoproteins with high sialic acid content
12/19/2012EP2534173A1 Engineered cleavage half-domains
12/19/2012EP2534172A2 Compositions and methods for preventing or treating a human parvovirus infection
12/19/2012EP2534171A1 Modified adam disintegrin domain polypeptides and uses thereof
12/19/2012EP2533813A1 Igf-i poly (ethylene glycol) conjugates
12/19/2012EP2533808A1 Process for producing an allergen extract
12/19/2012EP2533806A2 Methods and materials for treating cancer
12/19/2012EP2533792A2 Chemical preparation of polyubiquitin chains
12/19/2012EP2533629A2 Methods and materials for producing transgenic artiodactyls
12/19/2012EP2460880A9 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells
12/19/2012CN102834521A Methods for enhancing by-products from fermentation processes
12/19/2012CN102834517A Polynucleotides encoding nf-yb originating in jatropha and utilization thereof
12/19/2012CN102834507A Construct for production of empty picornaviral capsids
12/19/2012CN102834411A Peptides, devices, and methods for the detection of ehrlichia antibodies
12/19/2012CN102834410A Factor h binding proteins (fhbp) with altered properties and methods of use thereof
12/19/2012CN102834115A Recombinant human CC10 protein for treatment of influenza
12/19/2012CN102834109A Stable growth hormone compounds
12/19/2012CN102827857A Plasmid vector of L1 protein coding gene containing human papilloma virus 16 (HPV16) and construction method thereof
12/19/2012CN102827481A Keratin high-elasticity and high-flexibility biological film and preparation method thereof
12/19/2012CN102827283A Transgenic non-human animals capable of producing heterologous antibodies
12/19/2012CN102827271A Synthesis method of artificial antigen suitable for aminoazobenzene
12/19/2012CN102827270A Pegylated exenatide ramification and use thereof
12/19/2012CN102827269A Thymulin alpha 1 analog and preparation method thereof
12/19/2012CN102827268A Novel vasoactive intestinal peptide analog, and preparation method and usage thereof
12/19/2012CN102827267A Humanized pika leptin protein, gene coding same and application thereof
12/19/2012CN102827266A Application of ligand antrum mucosal protein-18(AMP-18) of laminin receptor in treatment of tumor
12/19/2012CN102827265A Novel gene of sorting nexin (SNX) family and use thereof
12/19/2012CN102827264A Technology for separating ant maggot protein
12/19/2012CN102827263A Application of MuMADS2 to culturing of fruit quality-improved transgenic plant
12/19/2012CN102827262A OsMIOX protein and coding gene and drought defying application thereof
12/19/2012CN102827261A Recombinant antigenic protein for detecting west nile virus antibody, kit and application thereof
12/19/2012CN102827260A Recombinant antigen protein for detecting yellow fever virus antibody, kit and application of recombinant antigen protein
12/19/2012CN102827259A Porcine circovirus type 2 (PCV2) Cap protein gene and application thereof
12/19/2012CN102827258A Method for purifying Enfuvirtide
12/19/2012CN102827257A Peptide fragment of gp96 protein and applications thereof
12/19/2012CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof
12/19/2012CN102827222A Hapten, artificial antigen and monoclonal antibody for tylosin and preparation methods and applications thereof
12/19/2012CN102827188A Universal hapten, artificial antigen and broad-spectrum monoclonal antibody for penicillin medicaments and preparation methods and applications thereof
12/19/2012CN102827076A Universal hapten of fluoroquinolone medicines, artificial antigen, broad-spectrum monoclonal antibody, preparation method and application
12/19/2012CN102827054A Hapten of L-hydroxyproline, artificial antigen, monoclonal antibody, preparation method and application
12/19/2012CN102206693B Production method of metallothionein of cordyceps sinensis
12/19/2012CN102174518B Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application
12/19/2012CN102040658B Schistosoma japonica polypeptide with immunogenicity and application thereof
12/19/2012CN102021175B Optimized grass carp alpha interferon encoding gene and application thereof
12/19/2012CN102002097B Mutant protein capable of being combined with nisin, and coded gene and application thereof
12/19/2012CN101921778B Gene DvCRP1 with Cd<2+> and Cu<2+> resistance as well as coding protein and application thereof
12/19/2012CN101891798B Method for separating and purifying curcin from seeds of jatropha curcas
12/19/2012CN101679968B Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
12/19/2012CN101437540B Melanocortin receptor binding mimetibodies, compositions, methods and uses
12/19/2012CN101301475B Peg化因子vii糖型 Peg factor vii sugar type
12/19/2012CN101242858B Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
12/19/2012CN101137751B Molybdenum transporter and gene thereof
12/19/2012CN101065398B Peptides and APL-type derivatives of hsp60 and pharmaceutical compositions
12/18/2012US8334442 Inbred maize variety PH17PK
12/18/2012US8334431 AXMI-115, AXMI-113, AXMI-005, AXMI-163 and AXMI-184: insecticidal proteins and methods for their use
12/18/2012US8334368 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
12/18/2012US8334367 T2R taste receptors and genes encoding same
12/18/2012US8334366 Mutant lycotoxin-1 peptide sequences for insecticidal and cell membrane altering properties
12/18/2012US8334365 Albumin fusion proteins
12/18/2012US8334275 Cellular genes regulated by HIV-1 infection and methods of use thereof
12/18/2012US8334264 Therapeutic use of a growth factor, METRNL
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8334255 Peptide and treatment for HIV-1 infection
12/18/2012US8334254 Recombinant lactoferrins, methods of production from plants and uses thereof
12/18/2012US8334253 Cosmetic and dermatological formulations of MNTF peptides
12/18/2012US8334146 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/18/2012US8334114 Lactoferrin cleavage of neisserial proteins
12/18/2012US8334108 Kit for protein S functional assay
12/18/2012US8334102 Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes
12/18/2012US8333974 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
12/18/2012US8333972 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
12/18/2012US8333963 Method of inhibiting osteoclast activity
12/18/2012US8333962 Controlled release multidrug formulations for spinal cord injury
12/18/2012US8333953 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2715575C Method to detect candida species
12/18/2012CA2524002C Sars-related proteins
12/18/2012CA2519059C Physiologically active polypeptide conjugate having prolonged in vivo half-life
12/18/2012CA2509980C Adenoviral vector vaccine
12/18/2012CA2501864C Methods and systems for detecting mhc class i and class ii binding peptides
12/18/2012CA2489275C Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests for diagnosis and management of aisnhl
12/18/2012CA2460468C Novel polypeptide, dna thereof and use of the same
12/18/2012CA2451173C Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies
12/18/2012CA2436057C A method for identification, isolation and production of antigens to a specific pathogen
12/18/2012CA2407895C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
12/18/2012CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
12/18/2012CA2385122C Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
12/18/2012CA2345109C Receptor based antagonists and methods of making and using
12/18/2012CA2327382C Neovascularization inhibitors
12/13/2012WO2012170993A2 Assays and methods pertaining to pre-amyloid intermediates
12/13/2012WO2012170938A1 Compositions and methods for increasing serum half-life
12/13/2012WO2012170782A2 Production of post-translationally hydroxylated recombinant proteins in bacteria
12/13/2012WO2012170617A1 Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes
12/13/2012WO2012170531A1 Hepatocyte based insulin gene therapy for diabetes
12/13/2012WO2012170524A1 Use of modified vasoactive intestinal peptides in the treatment of hypertension
12/13/2012WO2012170289A1 Method of producing factor viii proteins by recombinant methods
12/13/2012WO2012170084A1 Composition and method for treating lung disease and mucous cell metaplasia
12/13/2012WO2012169911A1 Peptides, constructs and uses therefor
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 2916